Woman Awarded $6.3M For Breast Cancer Caused By Hormone Therapy Use
PHILADELPHIA — A Pennsylvania state court jury on Nov. 20 awarded $6.3 million in compensatory damages to an Illinois woman after finding that her use of Wyeth’s Premarin and Prempro and Pharmacia & Upjohn’s Provera for nearly 11 years was a proximate cause of her development of breast cancer (Donna Kendall v. Wyeth Pharmaceuticals Inc., et al., No. 040600965, Pa. Comm. Pls., Philadelphia Co.).
Full story on lexis.com
Original post by LexisNexis® Mealey’sâ„¢ Legal News